Approvals/CIMA-AEMPS/NEXVIADYME 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

NEXVIADYME 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Sanofi B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 22634503fe450d0a
Drug Cima Aemps Name: NEXVIADYME 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211579001
Holder Company Name: Sanofi B.V.
Marketing Company Name: Sanofi Aventis S.A.
Holder Company Detail Path: /organization/sanofi-b-v
Authorization Date: 2022-09-07
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 100 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Sanofi B.V.
Company Detail Path: /organization/sanofi-b-v

AVALGLUCOSIDASA ALFA

10 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 7, 2022

Approval ID

22634503fe450d0a

Type

Standard